Prevalence and immunopathologic characteristics of seropositive and seronegative hepatitis B virus-associated membranous nephropathy: a retrospective study of 420 biopsy-proven cases

Prevalence and immunopathologic characteristics of seropositive and seronegative hepatitis B virus-associated membranous nephropathy: a retrospective study of 420 biopsy-proven cases

Background This retrospective study aims to investigate the prevalence and immunopathologic characteristics of seropositive and seronegative hepatitis B virus-associated membranous nephropathy (HBV-MN).Methods Clinicopathologic and serologic records of 420 patients with histologically confirmed HBV-...

Full description

Saved in:

Bibliographic Details
Main Authors:	Haitao Lu, Qianqian Xu, Guming Zou, Hongmei Gao, Yue Yang, Wenge Li, Li Zhuo
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2024-12-01
Series:	Renal Failure
Subjects:	Hepatitis B virus HBV-associated membranous nephropathy (HBV-MN) seroprevalence membranous nephropathy (MN) anti-phospholipase A2 receptor antibody
Online Access:	https://www.tandfonline.com/doi/10.1080/0886022X.2024.2313180
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Primary Membranous Nephropathy with Crescents
by: Megana Sunder, et al.
Published: (2023-10-01)

Current research status of PLA2R and malignancy associated membranous nephropathy
by: Zhu Wan-ting, et al.
Published: (2021-01-01)

Seropositivity and coinfection of hepatitis B and hepatitis C viruses in Central India: A hospital-based study
by: Rajeev K. Jain, et al.
Published: (2024-10-01)

Case report: Nephrotic syndrome and portal hypertensive ascites after allogeneic hematopoietic stem cell transplantation: a rare manifestation of chronic graft-versus-host disease
by: SanXi Ai, et al.
Published: (2024-10-01)

Research progresson correlation of PLA2R1 and HLA gene polymorphisms with susceptibility toidiopathic membranous nephropathy
by: XIE Da-xing, et al.
Published: (2019-01-01)

PLA2R-associated membranous nephropathy associated with renal clear cell carcinoma: one case report
by: Xu Xiao-chang, et al.
Published: (2021-01-01)

Clinicopathological characteristics of idiopathic membranous nephropathy in 65 elderly patients
by: LIU Wen-xue, et al.
Published: (2017-01-01)

Value of M-type phospholipase A2 receptor in clinical diagnosis and treatment of membranous nephropathy:recent advances and current controversies
by: Wang Hui, et al.
Published: (2021-01-01)

Biopsy-Proven Glomerulopathies in Romania: A 10-Year Nationwide Study
by: Andreea Covic, et al.
Published: (2025-06-01)

Serumanti-PLA2R antibody predicted treatment outcome in idiopathic membranous nephropathy
by: Zhang Xue-qin, et al.
Published: (2021-01-01)

The correlation between anti-phospholipase A2 receptor antibodies and hypercoagulability in patients with idiopathic membranous nephropathy
by: Yunyun Liu, et al.
Published: (2024-12-01)

Study on predictors for treatment efficacy of rituximab in patients with PLA2R-negative primary membranous nephropathy
by: XU Lili, HU Xiaofan, LI Hao, WANG Weiming
Published: (2025-06-01)

Predictive value of serum IgG/C3 levels for membranous nephropathy in diabetics with proteinuria and negative phospholipase A2 receptor antibody
by: Huan Wang, et al.
Published: (2024-12-01)

Seroprevalence of hepatitis B: Do blood donors represent the general population?
by: Hayat Kumbasar Karaosmanoglu, et al.
Published: (2011-09-01)

Efficacy and safety of obinutuzumab in primary membranous nephropathy: a real-world retrospective study
by: Xi Cheng, et al.
Published: (2025-08-01)

Case report: Coexistence of optic neuritis and primary anti-PLA2R-positive membranous nephropathy
by: Xi Wang, et al.
Published: (2025-03-01)

Target Antigens of Membranous Nephropathy With Syphilis Infection
by: Liyin Zhang, et al.
Published: (2024-02-01)

Fibrinogen-albumin ratio predicts treatment response in phospholipase A2 receptor-associated membranous nephropathy with nephrotic syndrome
by: Suyan Duan, et al.
Published: (2024-12-01)

The study of correlation between serum anti-phospholipase A2 receptor antibody and clinicopathology feature and the efficacy in patients with idiopathic membranous nephropathy
by: LI Wen-dong, et al.
Published: (2020-01-01)

Clinical features of anemia in membranous nephropathy patients: a Chinese cohort study
by: Zhe Li, et al.
Published: (2023-12-01)

The dysbiosis of gut microbiota and dysregulation of metabolites in IgA nephropathy and membranous nephropathy
by: Lei Zhang, et al.
Published: (2025-07-01)

Clinical efficacy of tacrolimus combined with glucocorticoids for idiopathic membranous nephropathy
by: LING Yi-sheng, et al.
Published: (2016-01-01)

Identification of novel therapeutic targets in hepatitis-B virus-associated membranous nephropathy using scRNA-seq and machine learning
by: Yongzheng Hu, et al.
Published: (2025-05-01)

The short-term clinical efficacy of 79 cases of idiopathic membranous nephropathy
by: LI Xiao-wei, et al.
Published: (2019-01-01)

241 cases of idiopathic membranous nephropathy patients with clinical and pathological correlation analysis
by: XU Dan, et al.
Published: (2015-01-01)

Transfusion-transmissible infections among blood donors in Kathmandu, Nepal
by: Ashish Chandra Shrestha, et al.
Published: (2009-11-01)

Seroprevalence and Risk Factors for Hepatitis B, Hepatitis C, and HIV in a Substance Abuse Treatment Center
by: Hatice Burcu Açıkalın Arıkan, et al.
Published: (2024-07-01)

Phase 1b/2a Study Assessing the Safety and Efficacy of Felzartamab in Anti-Phospholipase A2 Receptor Autoantibody–Positive Primary Membranous Nephropathy
by: Brad H. Rovin, et al.
Published: (2024-09-01)

The significance of anti-PLA2R antibody in the diagnosis and treatment of primary membranous nephropathy
by: XU Dong-mei, et al.
Published: (2019-01-01)

The essential role of electron microscopy in the diagnosis of collagen type III glomerulopathy superimposed with membranous nephropathy or diabetic nephropathy
by: Fangcheng Zhang, et al.
Published: (2025-07-01)

Clinical pathological analysis of 9825 cases of renal biopsy
by: FANG Ai-ju, et al.
Published: (2019-01-01)

Expression and significance of phospholipase A2 receptor and thrombospondin type-1 domain 7A in idiopathic membranous nephropathy
by: LI Fei, et al.
Published: (2019-01-01)

A retrospective study of calcineurin inhibitors in the treatment of idiopathic membranous nephropathy
by: CUI Lin-lin, et al.
Published: (2015-01-01)

Research advances of idiopathic membranous nephropathy with non-nephrotic range proteinuria
by: Sun Jing, et al.
Published: (2022-10-01)

Meta-analysis of calcineurin inhibitor vs.cyclophosphamide in the treatment of idiopathic membranous nephropathy
by: XIE Guang-liang, et al.
Published: (2015-01-01)

Clinical analysis of low-dos erituximab in the treatment of refractory idiopathic membranous nephropathy
by: Yuan Zhong-fei, et al.
Published: (2021-01-01)

Membranous nephropathy plus gastric adenocarcinoma tissue positive for neural epidermal growth factor-like 1:one case report with a literature review
by: Wei-dong Yang, et al.
Published: (2024-09-01)

A controlled clinical study of efficacy of different treatment regimens for idiopathic membranous nephropathy
by: LUO Man-yu, et al.
Published: (2019-01-01)

Changes in the spectrum of kidney diseases: a 14-year single-center retrospective renal biopsy study from southeast China
by: Zishan Lin, et al.
Published: (2025-04-01)

Clinical observation of responses to two plasma concentrations of tacrolimus in treatment of idiopathic membranous nephropathy stage Ⅱ
by: LI Xiao-yong
Published: (2019-01-01)